TOKYO - A health ministry panel may decide as early as May 20 whether to approve Moderna Inc.'s COVID-19 vaccine for use in Japan, government sources said Tuesday, possibly paving the way for a second type of shot to be available in the country after the one developed by Pfizer Inc.
Sorry. This article is no longer available.
Sorry, this article was first published more than three months ago and is temporarily unavailable.
Once the upcoming introduction of a paid membership system is fully operational, paid members will have access to all our stories.
Free Membership Provides
Newsletter from Editorial Team and access to archive articles from past three months.
By continuing, you agree to the Terms of Use,
and Privacy Policy.
